Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZMPSTE24 is a zinc-dependent transmembrane metalloprotease that plays a critical role in the post-translational processing of prelamin A, an essential step for the maturation of lamin A, a key structural component of the nuclear lamina. It catalyzes two sequential proteolytic cleavages on prelamin A: first, removing the C-terminal “aaX” tripeptide after farnesylation, and second, cleaving off an additional 15 amino acids upstream. This activity is essential for normal nuclear architecture and function. Mutations in ZMPSTE24 cause defective processing of prelamin A, leading to several severe disorders, including Hutchinson-Gilford Progeria Syndrome, mandibuloacral dysplasia, and restrictive dermopathy. It also plays a role in protein quality control, membrane stress response, and antiviral defense.
Proteolytic cleavage of prelamin A at the CAAX motif and upstream sequences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc metalloprotease ZMPSTE24 (ZMPSTE24).